Alejandro Ibáñez‐Costa

This study investigates the relationship between spliceosomic changes and patient survival in advanced SI-NETs, identifying CPSF2 as a key factor linked to poor prognosis.

This study identifies three distinct spliceosomic profiles in pancreatic neuroendocrine tumors linked to clinical and molecular characteristics and potential therapeutic targets.

This study identifies EIF4A3 as an oncogenic factor in PDAC by showing its overexpression correlates with poor prognosis and its role in regulating RNA splicing and tumor growth.

The paper uses immunophenotyping to identify patient subgroups in systemic autoimmune diseases, revealing shared immunophenotypes and cytokine signatures across different diagnoses.

The paper identifies DDX11 as a novel SLE gene through genomic convergence of GWAS and gene expression data, showing its repression in SLE and potential as a diagnostic tool.